While GHSR agonists, such as ibutamoren96 or anamorelin,97 are already on the market, due to inconsistent data on safety and effectiveness, there are yet no anti‐obesity drugs targeting the ghrelin signaling cascade.98, 99, 100. Here, GHSR is linked to obesity disorder.